Critics of Senate Bill 277, which would eliminate the personal belief and religious exemptions for schoolchildren, accuse the measure’s supporters in the Legislature of doing the bidding of donors who make vaccines and other pharmaceuticals.
The bill’s proponents and drug companies dismiss the charge. The companies’ lobbyist filings for the first quarter of this year as well as legislative committee reports show no connection between the pharmaceutical industry and SB 277.
“We aren’t pushing this bill behind the scenes,” said Priscilla VanderVeer, the senior director for communications for the Pharmaceutical Research and Manufacturers of America, known as PhRMA, the industry’s main trade group. The group has no taken no position on SB 277, although the group has long backed vaccinations as sound public health policy, she said.
Other legislation has a more direct bearing on the industry, and it is an active political player. Pharmaceutical companies and their trade groups gave more than $2 million to current members of the Legislature in 2013-2014, about 2 percent of the total raised, records show. Nine of the top 20 recipients are either legislative leaders or serve on either the Assembly or Senate health committees. Receiving more than $95,000, the top recipient of industry campaign cash is Sen. Richard Pan, a Sacramento Democrat and doctor who is carrying the vaccine bill.
In addition, the industry donated more than $500,000 to outside campaign spending groups that helped elect some current members last year.
Leading pharmaceutical companies also spent nearly $3 million more during the 2013-2014 legislative session lobbying the Legislature, the governor, the state pharmacists’ board and other agencies, according to state filings.
TOP DRUG MAKER DONORS
State records show that pharmaceutical companies and trade groups donated more than $2 million to current lawmakers in 2013-2014.
|Pharmaceutical company or group||Campaign donations to current state legislators||Direct lobbying payments|
|Johnson & Johnson Inc.||$86,300||$583,926|
|Eli Lilly & Company||$193,100||$280,863|
|Gilead Sciences Inc.||$77,600||$196,732|
|Astellas Pharma US Inc.||$47,900||$161,440|
|AstraZeneca Pharmaceuticals LLP||$157,300||$49,583|
|Merck & Co. Inc.||$91,600||$108,204|
|California Pharmacists Association||$53,389||$134,176|
|Pharmaceutical Research & Manufacturers Assn.||$137,950||$45,455|
|Bristol-Myers Squibb Company||$32,300||$144,101|
|Allergan USA Inc.||$120,100||$22,757|
|Takeda Pharmaceuticals USA Inc.||$40,000||$83,348|
|Pharmacy Professionals of California||$32,000||$0|
TOP DRUG MAKER RECIPIENTS
|Sen. Richard Pan*||D-Sacramento||$95,150|
|Assembly Speaker Toni Atkins||D-San Diego||$90,250|
|Sen. Ed Hernandez*||D-Azusa||$67,750|
|Sen. Holly Mitchell*||D-Los Angeles||$60,107|
|Assemblyman Brian Maienschein*||R-San Diego||$59,879|
|Senate President Pro Tem Kevin de León||D-Los Angeles||$56,648|
|Sen. Isadore Hall||D-Compton||$52,400|
|Sen. Jerry Hill||D-San Mateo||$50,209|
|Assemblyman Henry Perea||D-Fresno||$49,550|
|Assemblywoman Shirley Weber||D-San Diego||$47,000|
|Assemblyman Mike Gatto||D-Los Angeles||$46,491|
|Assemblywoman Susan A. Bonilla*||D-Concord||$45,600|
|Sen. Andy Vidak||R-Hanford||$42,800|
|Assemblyman Tom Daly||D-Anaheim||$40,300|
|Assemblyman Kevin Mullin||D-South San Francisco||$38,400|
|Assemblyman Adam Gray||D-Merced||$37,000|
|Assemblyman Rob Bonta*||D-Alameda||$36,750|
|Assemblyman Anthony Rendon||D-Lakewood||$36,200|
|Assemblyman Jimmy Gomez*||D-Los Angeles||$33,850|
|Assemblyman Richard Gordon||D-Menlo Park||$33,100|
*Member of the Assembly or Senate health committees
Source: Bee analysis of secretary of state campaign finance and lobbying reports
Contact her directly: email@example.com
Latest posts by Wendy Silvers (see all)
- The Harvey Weinstein Archetype - October 23, 2017
- LA Times — How to talk with your kids about the Violence in Charlottesville - August 14, 2017
- Robert F. Kennedy, Jr and Robert DeNiro host February 15 Press Conference at National Press Club - February 14, 2017